Trend Signal

Mentions trend ✨ New
30j7jNow

6

mentions (7d)

6

mentions (30d)

Jul 17, 2026

first seen

1

countries

Context & Analysis

This trend "Azitra's ATR-COSF elasticity-promoting cosmetic ingredient ex vivo results" was detected in the Beauty & Cosmetics category with a score of 100/100. This trend is experiencing explosive growth and attracting significant attention right now.

Related entities

/goto?url=CAESagHuR6pNaJkzvzAI5FbopzdQ_UjSdDzfwhIBhSLwiou3xWttpwCTHCyJNkmVdIg91J44fnjKJNEMF1Uhhqlqghx_ZatSeeLExUgjD2y3aIiNkLTu5BViT2xNACbGPHRgJx58xx__BGhJNew=https://www.prnewswire.com/news-releases/azitra-inc-announces-breakthough-repeat-dose-and-anti-wrinkle-ex-vivo-results-for-atr-cosf-program-demonstrating-increased-distribution-and-elasticity-302826522.htmlhttps://www.trendhunter.com/amp/trends/atrcosf-programhttps://www.personalcareinsights.com/news/azitra-filaggrin-anti-wrinkle-results.htmlhttps://pluang.com/en/news-feed/azitra-inc-umumkan-hasil-positif-eksperimen-anti-kerut-dan-distribusi-produk-atrhttps://www.aol.com/articles/azitra-inc-announces-breakthough-repeat-141000000.html

What sources say

  • "Azitra announced promising ex vivo results for its ATR-COSF program, a cosmetic ingredient formulated to promote skin elasticity."

    unknown

  • "In the news release, Azitra, Inc. Announces Breakthrough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Increased..."

    prnewswire.com

  • "ATR-COSF program - Clinical-stage biopharmaceutical company Azitra has announced promising ex vivo results for its ATR-COSF program — a cosmetic ingredient."

    trendhunter.com

  • "Azitra, a clinical-stage biopharmaceutical company, has revealed that its anti-aging ingredient, currently in development, shows “promising” applications."

    personalcareinsights.com

  • "Azitra, Inc. announced positive results from ex vivo human skin studies on its ATR-COSF program, which uses a supernatant containing a recombinant human..."

    pluang.com

  • "In the news release, Azitra, Inc. Announces Breakthrough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Increased..."

    aol.com

Share this trend

X LinkedIn